Viridian Therapeutics, Inc.\DE (VRDN) Shares Outstanding (2013 - 2026)

Viridian Therapeutics, Inc.\DE's Shares Outstanding (Entity) history runs 6 years deep, the most recent figure standing at $11.9 million for Q4 2021.

• On a quarterly basis, Shares Outstanding (Entity) rose 181.69% year-over-year to $11.9 million in Q4 2021; TTM through Dec 2021 was $11.9 million, a 181.69% increase from a year earlier, with the FY2021 full-year figure at $11.9 million, up 181.69% from the prior year.
• Shares Outstanding (Entity) improved to $11.9 million in Q4 2021 per VRDN's latest filing, from $11.2 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $11.9 million in Q4 2021 and bottomed at $770391.0 in Q1 2017.
• The 5-year median for Shares Outstanding (Entity) is $2.1 million (2019), against an average of $3.8 million.
• Across the five-year window, Shares Outstanding (Entity) grew 1.13% in 2019 and jumped 193.91% in 2021, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $1.5 million in 2017, then jumped by 36.65% to $2.1 million in 2018, then increased by 13.04% to $2.3 million in 2019, then surged by 82.04% to $4.2 million in 2020, then jumped by 181.69% to $11.9 million in 2021.
• Per Business Quant, the three latest VRDN Shares Outstanding (Entity) figures stand at $11.9 million (Q4 2021), $11.2 million (Q3 2021), and $8.6 million (Q2 2021).